Haoxi Health Technology Limited (HAO) Fair Value 2026

HAO · Services-Advertising Agencies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.4 /10

32 fundamental signals · 6 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-13, Haoxi Health Technology Limited (HAO) trades at $0.27, approximately 49% below CirclFi’s Bayesian DCF fair value of $0.52. QOC: 2.4/10. 6/13 models active.

Key Facts

Ticker
HAO
Price
$0.27
Quality Score
2.4/10
Value Trap Risk
—/100
Models Active
6/13
Last Updated
Strength: Bayesian DCF suggests +95.4% upside with 8% confidence
Risk: Below-average Quality Score of 2.4/10 signals weak fundamentals

Valuation Matrix

6 Intrinsic Value Models vs. Current Price ($0.27)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$0.52 +95.4%
Earnings Power Value
Medium Conviction
$0.04 -84.1%
RCMH-DCF
Medium Conviction
$0.02 -92.3%

Unlock the Full Matrix

Access 3 additional models including EROIC Spread, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is Haoxi Health Technology Limited (HAO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Haoxi Health Technology Limited's intrinsic value is estimated at a composite fair value of $0.32. Trading at $0.27, the stock is approaching fair value or slight overvaluation (implied return of +19.9%), as 4 of 6 models suggest limited further upside. The most optimistic model, PWERM, places fair value at $1.16 (+338.1%), while RCMH-DCF — the most conservative — estimates $0.02 (-92.3%). This +430.4% gap reflects genuine analytical uncertainty about Haoxi Health Technology Limited's intrinsic worth.

What Do the Models Say About HAO?

6 of 13 models are currently active for HAO. Of these, 2 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates HAO's intrinsic value at $0.52, implying +95.4% upside from the current price. See which stocks rank higher →

How Does HAO Rank in Services-Advertising Agencies?

Among 10 Services-Advertising Agencies stocks, HAO ranks #9 by Quality of Company score. CirclFi's QOC score of 2.4/10 evaluates 32 fundamental signals. A score of 2.4 signals below-average fundamentals.

Haoxi Health Technology Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HAO a Value Trap?

The Value Trap algorithm is not active for HAO. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for Haoxi Health Technology Limited. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Haoxi Health Technology Limited scores 2.4 out of 10 on our 32-signal quality assessment, a weak rating that exhibits fundamental weaknesses that warrant careful scrutiny. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +430.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HAO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HAO's 6 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Haoxi Health Technology Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Advertising Agencies Stocks Should You Also Analyze?

8 related Services-Advertising Agencies stocks with 13-model coverage

Read investment analysis: OMC · CRTO · TJGC · SWAG · WPP

Frequently Asked Questions About Haoxi Health Technology Limited

What is Haoxi Health Technology Limited's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Haoxi Health Technology Limited (HAO) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.52. The Quality of Company score is 2.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HAO overvalued or undervalued right now?

At $0.27, 2 of 6 active models suggest HAO may be undervalued, while 4 indicate potential overvaluation. The assessment depends on which methodology best fits Haoxi Health Technology Limited's business model in Services-Advertising Agencies.

What does a Quality of Company score of 2.4 mean for HAO?

Haoxi Health Technology Limited's QOC of 2.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on HAO?

CirclFi analyzes HAO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Is HAO a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for HAO at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on HAO.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access